Caribou Biosciences CRBU
NASDAQ CRBU
$0.56 +0.02 (+2.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Preferred Shares (2021)

Updated

Caribou Biosciences' Preferred Shares was $150.15 million in Q2 2021.

Analysis

Caribou Biosciences (CRBU) Preferred Shares (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Caribou Biosciences 56.06 Mn -460.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 150.15 Mn
API Access

Caribou Biosciences Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=CRBU&period=max&api_key=YOUR_API_KEY